By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

Novo Nordisk launches Awiqli, the world's first once-weekly insulin, in India to revolutionize diabetes management.

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

Adolescents can sometimes miss mealtime insulin because it’s hard to take a shot in front of other people,” Dr. Risa Wolf ...

A major breakthrough for diabetes care has arrived in India. Novo Nordisk has launched Awiqli, the world's first once-weekly ...

New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an ...

Insulin resistance may quietly reduce fertility in both men and women, even before diabetes develops. Fertility experts ...

Minnesota Attorney General Keith Ellison announced a settlement with CVS, holding the pharmacy chain accountable for years of ...

Minnesota Attorney General Keith Ellison announced the settlement Thursday, which includes a coalition of 37 attorneys ...